(A–C) TGFb1 mRNA expression by FACS-sorted BM conventional
eGFPCD4+ T cells, eGFPCD8+ T cells, and
eGFP+ Treg cells. DEREG (eGFP.Foxp3) reporter mice were treated
with vehicle, LGG, or butyrate for 4 weeks. BM cells were sorted at the end of
the treatment period.
(D) Immunoblot analysis for the detection of NFAT1, NFAT2, pSMAD2, and
pSMAD3 in purified BM CD8+ T cells.
(E) Immunoblot analysis for the detection of c-Jun and c-Fos in
purified BM CD8+ T cells.
(D and E) Fresh BM CD8+ T cells were pooled together and
then used for obtaining nuclear and cytoplasmic fractions. Laminin B1 was used
as nuclear loading control. Tubulin was used as cytoplasmic loading control.
(F) Immunoblot analysis for the detection of Phospho-PI3K p85 in the
whole lysate from BM CD8+ T cells.
(G and H) pAKT levels in BM CD8+ T cells and percent of
pAKT+ BM CD8+ T cells, as determined by flow
cytometry.
(D–F) Conventionally raised WT mice were treated with vehicle,
LGG, or butyrate for 4 weeks. BM CD8+ T cells were purified at the
end of the treatment period using the EasySep Mouse CD8+ T Cell
Isolation Kit. One representative experiment of 3 experiments.
Data were expressed as mean ± SEM, n = 5–10 mice per
group in (A)–(C), (G), and (H). Data were analyzed by two-way ANOVA and
post hoc tests applying the Bonferroni correction for multiple comparisons. **p
< 0.01, ***p < 0.001, and ****p < 0.0001 compared to
vehicle or the indicated group. ns = not significant.